HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oreal Powering Down Clarisonic After 16 Years Of Innovation, More Than 15 Million Devices Sold

Executive Summary

The decision to close Clarisonic follows a 234m impairment charge recorded in 2016 and comes as L’Oreal faces tough strategic decisions in a global economy ravaged by the COVID-19 crisis.

You may also be interested in...



After Clarisonic: Device Brand’s Founder Primes Opulus For Launch In New Beauty Tech Era

This fall, Robb Akridge’s Opulus Beauty Labs will be launching stripped-down, “peak potency” skin-care formulas in the form of Opoules that users warm and blend in an Activator appliance, providing fresh, single-dose treatments. The system bears similarities to Swiss startup Réduit’s Hairpods and applicator device, as well as L’Oreal’s AI-powered Perso, slated to debut in 2021.

L’Oreal Defeats Slack-Fill Case In New York, Pivots To Clarisonic ‘Defect’ Complaint In California

L’Oreal USA beat a suit in May in New York regarding liquid cosmetics packaging, which plaintiffs alleged cheated consumers out of product they expected to be accessible, only to face a newly proposed class action, filed in California on 5 June, over an alleged Clarisonic waterproofing defect.

L’Oreal Optimistic About Post-Shutdown Growth, Notes Likely Thinning Of Beauty Field

“It's unfortunate, but it's the Darwinian side of this industry,” L’Oreal CEO Jean-Paul Agon said on 16 April while discussing newer players’ prospects for survival through the COVID-19 crisis and L’Oreal’s own first-quarter results – down 4.8% like-for-like, but ahead of the market.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1131867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel